HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Smooth muscle proliferation in chronically injured canine pulmonary arteries is reduced by a potent platelet aggregation inhibitor U-53,059.

Abstract
Dirofilaria immitis (DI) infection chronically injures canine pulmonary arteries. This injury produces endothelial cell loss, platelet/leukocyte adhesion, and smooth muscle proliferation. In the present study we assessed the effect of the cyclooxygenase inhibitor, U-53,059, on platelet function, platelet kinetics, coagulation, and smooth muscle proliferation in DI infected dogs. Platelet aggregation to the combination of arachidonic acid/ADP was significantly inhibited by U-53,059. Coagulation and hematologic parameters were not effected by either DI infection or U-53,059 treatment. Platelet survival and the number of platelet dense granules were reduced in DI infection. Quantification of the lesions demonstrated that U-53,059 reduced both severity and density compared to non-treated dogs. U-53,059 is a potent and effective inhibitor of platelet aggregation which modifies smooth muscle proliferation produced by chronic vascular injury.
AuthorsR G Schaub, J C Keith Jr, C A Simmons, C A Rawlings
JournalThrombosis and haemostasis (Thromb Haemost) Vol. 53 Issue 3 Pg. 351-5 (Jun 24 1985) ISSN: 0340-6245 [Print] Germany
PMID4049309 (Publication Type: Journal Article)
Chemical References
  • Thiazoles
  • itazigrel
Topics
  • Animals
  • Blood Platelets (drug effects, ultrastructure)
  • Cell Division (drug effects)
  • Dirofilaria immitis (pathogenicity)
  • Dirofilariasis (blood, pathology, physiopathology)
  • Dogs
  • Female
  • Male
  • Microscopy, Electron
  • Muscle, Smooth, Vascular (drug effects, pathology, ultrastructure)
  • Platelet Aggregation (drug effects)
  • Pulmonary Artery (drug effects, pathology, ultrastructure)
  • Thiazoles (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: